Thigpen JT, Blessing JA, Homesley H, et al. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 1989;33:68–70.
378.
Long HJ, Pfeiﬂe DM, Wieand HS, et al. Phase II evaluation of carboplatin in advanced endometrial carcinoma. J Natl Cancer Inst 1988;80:276–278.
385.
Miller DS, Blessing JA, Lentz SS, et al. A phase II trial of topotecan in patients with advanced, persistent, or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gyneocol Oncol 2002;87:247–251.
386.
Wadler S, Levy DE, Lincoln ST, et al. Topotecan is an active agent in first line treatment of metastatic or recurrent endometrial carcinoma. Eastern Oncology Cooperative Group Study E3E93. J Clin Oncol 2003;21:2110–2114.
387.
Aapro MS, van Wijk FH, Bolis G, et al. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomized study by the EORTC Gynecologic Cancer Group. Ann Oncol 2003;14:441–448.
388.
Edmonson JH, Krook JE, Hilton JF, et al. Randomized phase II studies of cisplatin and a combination of a cyclophosphamidedoxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma. Gynecol Oncol 1987;28:20– 24.
389.
Burke TW, Stringer CA, Morris M, et al. Prospective treatment of advanced or recurrent endometrioid carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol 1991;40:264– 267.
390.
Dimopoulos MP, Papadimitriou CA, Georgoulias V, et al. Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study. Gynecol Oncol 2000;78:52–57.
391.
Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of 418.
Hauptman S, Nadjari B, Kraus J, et al. Uterine tumor resembling ovarian sex-cord tumor: a case report and review of the literature. Virchows Arch 2001;439:97–101.
419.
Taylor HB, Norris HJ. Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcoma. Arch Pathol 1966;82:40–44.
420.
Gudgeon DH. Leiomyosarcoma of the uterus. Obstet Gynecol 1968;32:96–100.
421.
Silverberg SG. Leiomyosarcoma of the uterus: a clinicopathologic study. ObstetGynecol 1971;38:613–628.
422.
Christopherson WM, Williamson EO, Gray LA. Leiomyosarcoma of the uterus.Cancer 1972;29:1512–1517.
423.